Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo.
Schiemann K, Belousova N, Matevossian A, Nallaparaju KC, Kradjian G, Pandya M, Chen Z, Aral E, Krauel EM, Petrova E, Boesler C, Kitzing T, Lecomte M, Wagner C, Blayo AL, Schann S, Huck B, Moisan J, Zaynagetdinov R.
Schiemann K, et al. Among authors: nallaparaju kc.
Mol Cancer Ther. 2024 Nov 4;23(11):1517-1529. doi: 10.1158/1535-7163.MCT-23-0843.
Mol Cancer Ther. 2024.
PMID: 39162025